AI Verdict
LEVI has stronger fundamentals based on our AI analysis.
LFCR vs LEVI Fundamental Comparison
| Metric | LFCR | LEVI |
|---|---|---|
| Revenue | $31.1M | $1.7B |
| Net Income | $-10.0M | $175.8M |
| Net Margin | -32.1% | 10.1% |
| ROE | N/A | 8.0% |
| ROA | -4.2% | 2.7% |
| Current Ratio | 2.80x | 1.58x |
| Debt/Equity | N/A | 0.48x |
| EPS | $-0.29 | $0.45 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LFCR vs LEVI: Frequently Asked Questions
Is LFCR or LEVI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LEVI has stronger fundamentals. LFCR is rated STRONG SELL (85% confidence) while LEVI is rated BUY (72% confidence). This is not investment advice.
How does LFCR compare to LEVI fundamentally?
LIFECORE BIOMEDICAL, INC. DE has ROE of N/A vs LEVI STRAUSS & CO's 8.0%. Net margins are -32.1% vs 10.1% respectively.
Which stock pays higher dividends, LFCR or LEVI?
LFCR has a dividend yield of N/A or no dividend while LEVI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LFCR or LEVI for long term?
For long-term investing, consider that LFCR has STRONG SELL rating with 85% confidence, while LEVI has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LFCR vs LEVI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LFCR vs LEVI, the AI consensus favors LEVI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.